Northwestern Mutual Wealth Management’s Beam Therapeutics BEAM Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43K	Buy	1,252 +1,167	+1,373%	+$35.2K	﹤0.01%	2596
2026 Q1	$2.03K	Buy	+85	New	+$2.36K	﹤0.01%	3594
2024 Q4	–	Sell	-24	Closed	-$588	–	3627
2024 Q3	$588	Buy	+24	New	+$620	﹤0.01%	3325
2024 Q1	–	Sell	-50	Closed	-$1.36K	–	3581
2023 Q4	$1.36K	Buy	+50	New	+$1.24K	﹤0.01%	3114
2022 Q1	–	Sell	-23	Closed	-$2K	–	3107
2021 Q4	$2K	Buy	+23	New	+$1.97K	﹤0.01%	2932

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Northwestern Mutual Wealth Management's BEAM Position: Q2 2026 in Review

Northwestern Mutual Wealth Management increased its Beam Therapeutics (BEAM) stake by 1,373% in Q2 2026, buying an estimated $35.2K and bringing the position to 1,252 shares worth $43K. The position accounts for ﹤0.01% of the portfolio, ranked #2596.

Northwestern Mutual Wealth Management first reported a position in BEAM in Q4 2021 and has held it in 5 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Northwestern Mutual Wealth Management held 1,252 shares of Beam Therapeutics worth $43K as of Q2 2026.
Northwestern Mutual Wealth Management bought 1,167 Beam Therapeutics shares in Q2 2026, an estimated $35.2K.
Beam Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #2596 holding.
Northwestern Mutual Wealth Management first reported a position in Beam Therapeutics in Q4 2021 and has held it in 5 quarters since.
277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.